|
| |
Articles
1-144 out of 144 article(s)
| Title |
Author |
Type |
Date |
Words |
| Heparin (CAS 9005-49-6) Market Research Report. |
|
Report |
Apr 11, 2013 |
377 |
| Heparin (CAS 9005-49-6) Market Research Report. |
|
Report |
Apr 11, 2013 |
371 |
| Heparin. |
|
|
Jan 18, 2013 |
162 |
| Research and Markets: China Heparin Industry Report, 2012-2014. |
|
Report |
Jan 11, 2013 |
570 |
| China Heparin Industry Report, 2012-2014. |
|
|
Dec 31, 2012 |
1957 |
| Research and Markets: Global Heparin Market 2011-2015. |
|
Industry overview |
Dec 4, 2012 |
660 |
| Global Heparin Market 2011-2015: MarketResearchReports.Biz. |
|
Industry overview |
Nov 21, 2012 |
1085 |
| Global Heparin Market 2011-2015: MarketResearchReports.Biz. |
|
Industry overview |
Nov 21, 2012 |
1090 |
| Research and Markets: Global Heparin Market: US, Europe, Japan. |
|
|
Feb 13, 2012 |
266 |
| Research and Markets: China's Heparin Industry Report, 2010-2011 Out Now. |
|
Report |
Oct 14, 2011 |
391 |
| Nolan Law Group: Jury Finds Against Baxter Healthcare In Nation's First Contaminated Chinese Heparin Case. |
|
|
Jun 9, 2011 |
485 |
| Gore Reports First Patient Treated in the United States using GORE[R] VIABAHN[R] Endoprosthesis with Heparin Bioactive Surface on a Lower Profile Delivery System. |
|
|
Mar 21, 2011 |
591 |
| Heparin plays key role in allergic, inflammatory reactions. |
|
|
Feb 27, 2011 |
233 |
| Stop that clot: haemostasis and anticoagulation: this is the first in a series of clinical articles Kai Tiaki Nursing New Zealand is publishing to provide a convenient way for nurses to earn continuing professional development hours. |
Casey, Georgina |
Report |
Feb 1, 2011 |
4569 |
| Reportlinker Adds Heparin: US, Europe, Japan: Test Volume Forecasts by Country and Market Segment through 2018. |
|
|
Jan 27, 2011 |
481 |
| For Managing PCI-Treated ACS, the Highest Proportion of Surveyed MCOs Select Aspirin/Clopidogrel/Enoxaparin and Aspirin/Clopidogrel/Unfractionated Heparin as Having the Best Overall Clinical Profile When Compared to Other Available Therapies. |
|
|
Jan 19, 2011 |
680 |
| Research and Markets: China Heparin Industry Report, 2010. |
|
Report |
Jan 17, 2011 |
624 |
| PolyMedix Presents PMX-60056 Clinical Data at American Society of Hematology Meeting. |
|
Clinical report |
Dec 7, 2010 |
975 |
| Food and Drug Administration: Response to Heparin Contamination Helped Protect Public Health; Controls That Were Needed for Working With External Entities Were Recently Added. |
|
|
Dec 1, 2010 |
647 |
| The effect of heparin on the cell cycle in human B-iymphoblasts: an in vitro study / Heparinin insan B-lenfositlerinin hucre dongusune etkisi: bir in vitro calisma. |
Aksoy, Ayse; Erduran, Erol; Tekelioglu, Yavuz; Mutlu, Mehmet; Gedik, Yusuf |
|
Dec 1, 2010 |
5859 |
| Scientific Protein Labs failed to report complaints about Chinese heparin: FDA. |
|
|
Nov 2, 2010 |
508 |
| B. Braun recalls heparin contaminated with oversulfated chondroitin sulfate. |
|
Brief article |
Nov 2, 2010 |
140 |
| Post-Market Approval Study of GORE[R] VIABAHN[R] Endoprosthesis with Heparin Bioactive Surface for Lower Limb Vascular Disease Completes Patient Enrollment. |
|
|
Sep 24, 2010 |
632 |
| PolyMedix Successfully Completes Phase 1B/2 Heparin Dose-Ranging Study with PMX-60056 Heptagonist. |
|
Report |
Aug 11, 2010 |
1357 |
| Congressmen press Hamburg on Chinese heparin. |
|
|
Aug 10, 2010 |
437 |
| Raising awareness of heparin-induced thrombocytopenia in subarachnoid hemorrhage. |
Robinson, Jennifer D. |
Clinical report |
Aug 1, 2010 |
2180 |
| Safety of percutaneous dilational tracheostomy in coagulopathic patients. |
Pandian, Vinciya; Vaswani, Ravi S.; Mirski, Marek A.; Haut, Elliott; Gupta, Shivam; Bhatti, Nasir I. |
|
Aug 1, 2010 |
3436 |
| B. Braun Large Volume Heparin Infusion Solutions Now Available. |
|
|
Jul 12, 2010 |
501 |
| APP Pharmaceuticals Announces Marketing Clearance of Preservative-Free Heparin Lock Flush Solution, USP. |
|
|
Jul 6, 2010 |
1011 |
| Validation of a dosing regimen for fixed-dose, weight-adjusted, subcutaneous unfractionated heparin for the acute treatment of venous thrombo-embolism in a population from a resource-constrained environment. |
Munsamy, J.I.; Kertland, H.; Parrish, A. |
Report |
Jul 1, 2010 |
1357 |
| FDA Approves Sagent Pharmaceuticals' Heparin Sodium Injection, USP. |
|
|
Jul 1, 2010 |
801 |
| Relationship of hemoglobin concentration to packed cell volume in avian blood samples. |
|
Report |
Jun 1, 2010 |
3654 |
| Lyophilized Heparin Preserves Cord Blood Stem Cells Better Than Commonly-Used Anticoagulant, Citrate Phosphate Dextrose. |
|
Clinical report |
May 25, 2010 |
1159 |
| Congress faults FDA in heparin case. |
|
|
May 18, 2010 |
372 |
| Endogenous heparin levels in the controlled asthmatic patient. |
Davids, Hajierah; Ahmed, Ayesha; Oberholster, Ari; van der Westhuizen, Christo; Mer, Mervyn; Havlik, |
|
May 1, 2010 |
1153 |
| PolyMedix Initiates Phase 1B/2 Dose-Ranging Clinical Study With PMX-60056 to Reverse Heparin. |
|
|
Apr 28, 2010 |
921 |
| Toddler may have died of heparin overdose. |
|
|
Apr 20, 2010 |
655 |
| Tests confirm that 'new' heparin is less potent. |
|
|
Apr 20, 2010 |
268 |
| Woodcock cleared of conflict-of-interest allegations in heparin case. |
|
|
Feb 9, 2010 |
534 |
| Starting heparin in the emergency department (ED) rather than after admission may improve the survival of patients with acute pulmonary embolism (PE), according to a Mayo Clinic study. |
|
Clinical report |
Feb 1, 2010 |
311 |
| PolyMedix to Host Webcast on Heparin, Bleeding Complications, and PolyMedix's PMX-60056 Reversing Agent Tuesday, December 15, 2009 at 10:00am-EST. |
|
|
Dec 9, 2009 |
624 |
| Incidence of anti-heparin/platelet factor 4 antibodies and heparin-induced thrombocytopenia in medical patients/Medikal hastalarda anti-heparin trombosit faktor 4 antikor ve heparine bagli trombositopeni sikligi. |
Demir, Muzaffer; Tekgunduz, Emre; Edis, Mustafa; Duran, Enver; Kurum, Turan; Yigitbasi, Omer; Yuksel |
Clinical report |
Dec 1, 2009 |
2615 |
| A case of heparin induced thrombocytopenia treated with fondaparinux/Fondaparinuxla tedavi edilen heparine bagli trombositopeni olgusu. |
Alpay, Nilufer; Okumus, Gulfer; Kiyan, Esen; Diz-Kucukkaya, Reyhan; Tabak, Levent; Ece, Turhan; Arse |
Report |
Dec 1, 2009 |
1819 |
| Pulmonary embolism in a patient with pernicious anemia: effects of inherited thrombophilia and acquired risk factors/Pernisyoz anemi'li bir olguda pulmoner emboli: kalitimsal trombofili ve kazanilmis risk faktorlerinin etkileri. |
Ceylan, Emel; Tas, Sule; Karadag, Fisun; Polatli, Mehmet; Cildag, Orhan |
Report |
Dec 1, 2009 |
2794 |
| Hospital-acquired malaria associated with dispensing diluted heparin solution. |
Al-Hamdan, Nasser A. |
Report |
Dec 1, 2009 |
873 |
| Heparin potency will change. |
|
Brief article |
Nov 1, 2009 |
174 |
| PolyMedix Completes Successful Phase 1B Clinical Study of Heparin Antagonist PMX-60056. |
|
|
Oct 27, 2009 |
1524 |
| Change in heparin manufacturing will decrease potency, protect quality: FDA. |
|
|
Oct 13, 2009 |
522 |
| APP Pharmaceutical Supports New USP Standards for Unfractionated Heparin. |
|
|
Oct 1, 2009 |
960 |
| Gore Receives FDA Approval for Next Generation of Large Diameter GORE VIABAHN[R] Endoprosthesis with Heparin Bioactive Surface. |
|
|
Jul 21, 2009 |
613 |
| Ligand Licenses Patents for Desulfated Heparin Technology to ParinGenix. |
|
|
Jun 25, 2009 |
581 |
| Delaware patients did not die due to heparin, Baxter says. |
|
|
May 19, 2009 |
331 |
| Qingdao Jiulong Biopharmaceuticals Qingdao, People's Republic of China April 14 (CDER). |
|
|
May 1, 2009 |
1082 |
| Shanghai No. 1 Biochemical & Pharmaceutical Co. Shanghai, People's Republic of China April 14 (CDER). |
|
|
May 1, 2009 |
864 |
| GMP violations cited at Qingdao Jiulong Biopharmaceuticals. |
Mashaw, Rebecca |
|
May 1, 2009 |
1079 |
| FDA cites heparin producer for outsourced manufacturing. |
Mashaw, Rebecca |
|
May 1, 2009 |
859 |
| PolyMedix Completes First-in-Man Phase I Clinical Study with Novel Heparin Antagonist PMX-60056. |
|
|
Mar 11, 2009 |
1485 |
| Lawmaker asks for heparin review. |
Anderson, Jane |
Brief article |
Jan 1, 2009 |
183 |
| APP Pharmaceuticals Launches Heparin-Focused Educational Web Site Called "Working Together For Patient Safety". |
|
|
Dec 5, 2008 |
882 |
| Resources aid attorneys representing clients harmed by heparin. |
|
|
Nov 1, 2008 |
401 |
| The use of alternative anti-coagulation strategies for a nocturnal home hemodialysis patient with heparin-induced thrombocytopenia. |
Faratro, Rose; D'Gama, Celine; Chan, Christopher |
Clinical report |
Oct 1, 2008 |
3377 |
| Safer blood thinner. |
Castelvecchi, Davide |
Brief article |
Sep 13, 2008 |
82 |
| APP Pharmaceuticals Receives Manufacturing Approval for Three Product Codes of Heparin at Puerto Rico Facility. |
|
|
Aug 18, 2008 |
486 |
| W. L. Gore & Associates Announces Positive Interim Study Results for GORE PROPATEN Vascular Graft and GORE VIABAHN Endoprosthesis With Heparin Bioactive Surface. |
|
Clinical report |
Jul 22, 2008 |
917 |
| Some cancers need prolonged, high-dose VTE prophylaxis. |
Zoler, Mitchel L. |
|
Jul 15, 2008 |
538 |
| ConsumerLab points out irony of heparin contamination with chondroitin; calls for better testing. |
Obermeyer, William |
Brief article |
Jul 1, 2008 |
276 |
| Heparin contamination. |
Klotter, Jule |
|
Jul 1, 2008 |
465 |
| Young South Florida Leukemia Patient Represented by Hannon & Boyers Sues Makers of Contaminated Heparin, Saline. |
|
|
Jun 26, 2008 |
620 |
| EU urges more collaboration after heparin scandal. |
|
|
Jun 17, 2008 |
323 |
| Health Canada warns about medical devices with heparin coating. |
|
|
Jun 17, 2008 |
350 |
| APP Pharmaceuticals Launches Enhanced Labeling for Heparin Sodium Injection, USP. |
|
|
Jun 2, 2008 |
949 |
| Heparin FDA recall for all provider types. |
|
|
Jun 1, 2008 |
86 |
| Medtronic recalls heparin-coated heart bypass medical devices. |
|
|
May 20, 2008 |
318 |
| APP Pharmaceuticals Provides Update on Issues Related to Heparin Crisis and Actions to Ensure Uninterrupted Safe Supply. |
|
|
May 15, 2008 |
1094 |
| Sanofi finds 'small amount' of impurity in heparin. |
|
Brief article |
May 6, 2008 |
274 |
| Heparin Sodium Injection, USP. |
|
Brief article |
May 6, 2008 |
200 |
| Heparin Sodium Injection, USP (porcine) 5,000 U/mL. |
|
Brief article |
May 6, 2008 |
202 |
| Results Published in JACC Show Clinical Advantage of Switching to Angiomax from Heparin in Acute Coronary Syndrome Patients Undergoing Early Invasive Treatment. |
|
|
May 5, 2008 |
1187 |
| Tracking Washington. |
|
Brief article |
May 5, 2008 |
239 |
| Baxter CEO says heparin contamination appears deliberate. |
|
Brief article |
May 5, 2008 |
201 |
| Heparin manufacturer warned for failing to remove impurities. |
Mashaw, Rebecca |
|
May 1, 2008 |
1048 |
| Heparin contaminant's tie to adverse events clear. |
Mechcatie, Elizabeth |
|
May 1, 2008 |
608 |
| US regulators suspect that Baxter International Inc's (Deerfield IL) blood-thinner heparin, linked to deaths and allergic reactions, was intentionally contaminated to boost profits. |
|
Brief article |
Apr 21, 2008 |
197 |
| Sixty-two people given the blood-thinner heparin died since January 2007 after suffering allergic reactions or low blood pressure, up from 19 previously reported, US regulators said. |
|
Brief article |
Apr 14, 2008 |
165 |
| Heparin recalled in Europe and Australia as Covidien initiates voluntary recall of syringes in U.S. |
|
|
Apr 8, 2008 |
565 |
| Personal Injury Lawsuit Filed Against Baxter for Near Fatal Adverse Reaction From Contaminated Heparin Drug. |
|
|
Apr 3, 2008 |
566 |
| Covidien Initiates Voluntary Recall of Pre-Filled Syringes Containing Heparin. |
|
Company overview |
Mar 28, 2008 |
436 |
| China orders tighter controls on heparin production; FDA establishes permanent presence in China. |
|
|
Mar 25, 2008 |
807 |
| Baxter's heparin contaminant identified. |
|
Brief article |
Mar 24, 2008 |
227 |
| Preventing substitution errors involving high-concentration heparin products. |
Koczmara, Christine; Cheng, Roger; Hyland, Sylvia |
|
Mar 22, 2008 |
2418 |
| B. Braun's Supplier Recall of Heparin API Prompts Voluntary Recall of Heparin Solutions. |
|
|
Mar 21, 2008 |
409 |
| American Health Packaging Announces a Recall of Approximately 1,400 Units of Heparin Sodium Vial Products as Part of Broader Baxter Recall. |
|
|
Mar 20, 2008 |
1016 |
| Baxter to proceed with recall of remaining heparin sodium vial products. |
|
|
Mar 11, 2008 |
536 |
| Changzhou cited for not removing impurities, checking OOS results: Changzhou SPL Company, Wujing, Changzhou City, China, CDER. |
|
|
Mar 1, 2008 |
469 |
| Legislators review FDA inspection policy after heparin adverse reactions. |
|
|
Feb 26, 2008 |
1040 |
| First Patient Enrolled in Study Evaluating Performance of Spectranetics Laser Ablation Followed by GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface. |
|
|
Feb 25, 2008 |
778 |
| APP Pharmaceuticals Announces Plan to Respond to Potential Therapeutic Heparin Shortage in the United States. |
|
|
Feb 19, 2008 |
689 |
| Baxter, AM2 PAT heparin, sodium injection lots recalled. |
|
Brief article |
Jan 29, 2008 |
270 |
| B. Braun's Supplier Prompts Voluntary Recall of All Lots and All Sizes of Pre-Filled Heparin and Normal Saline Flush Syringes. |
|
|
Jan 19, 2008 |
314 |
| Practice resource network. |
Leeper, A. Barbara |
|
Jan 1, 2008 |
1267 |
| Delayed hypersensitivity to low-molecular-weight heparin (LMWH) in pregnancy. |
Schapkaitz, E.; Jacobson, B.F. |
Clinical report |
Dec 1, 2007 |
1794 |
| First Patient Enrolled in Study of the GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface for Lower Limb Peripheral Vascular Disease. |
|
|
Oct 18, 2007 |
505 |
| The use of heparin in preparing samples for blood-gas analysis. |
Higgins, Chris |
|
Oct 1, 2007 |
5139 |
| Gore Receives FDA Approval For GORE VIABAHN(R) Endoprosthesis with Heparin Bioactive Surface. |
|
|
Sep 5, 2007 |
538 |
| Systemic anticoagulant effect of low-dose subcutaneous unfractionated heparin as determined using thrombelastography. |
Matzelle, S.J.; Gibbs, N.M.; Weightman, W.; Sheminant, M.; Rowe, R.; Baker, S. |
Clinical report |
Aug 1, 2007 |
3587 |
| Certain lots of Fraxiparine and Fraxiparine Forte syringes recalled. |
|
Brief article |
Jun 18, 2007 |
120 |
| Heparin is a widely used drug--just about any health worker will deal with patients on the drug. |
Opie, Jessica |
Clinical report |
Jun 1, 2007 |
2453 |
| New Study Shows Clexane(R) / Lovenox(R) (Enoxaparin Sodium Injection) is More Effective Than Unfractionated Heparin (UFH) for Preventing the Risk of Venous Thromboembolism (VTE) in Patients With Acute Ischemic Stroke. |
|
|
Dec 12, 2006 |
774 |
| Subcutaneous unfractionated heparin: ready for prime time? |
Ebbert, Jon O.; Tangalos, Eric G. |
|
Nov 15, 2006 |
832 |
| Old drug can stop clots as well as newer drug does. |
|
Brief article |
Sep 9, 2006 |
286 |
| The New England Journal of Medicine Publishes the STEEPLE Study Which Demonstrated Superior Safety Profile of LOVENOX(r) (Enoxaparin Sodium Injection) Vs. Unfractionated Heparin (UFH) in Patients Undergoing Non-Emergent Percutaneous Coronary Intervention (PCI). |
|
|
Sep 8, 2006 |
666 |
| Watch for heparin-induced thrombocytopenia. |
Jancin, Bruce |
Clinical report |
Aug 15, 2006 |
565 |
| Answering your questions; Heparin drawing tubes. |
Baer, Daniel M. |
Column |
Aug 1, 2006 |
619 |
| Heparin fails to cut rate of DVT/PE after prostatectomy. |
|
|
Aug 1, 2006 |
481 |
| Who is responsible? |
Bayley, Carol; Berlinger, Nancy |
|
May 1, 2006 |
1650 |
| FDA alert on NaCl, heparin preloaded IV Flush syringes. |
Wachter, Kerri |
Brief Article |
May 1, 2005 |
95 |
| Low-molecular-weight heparin helps in acute MI. |
Zoler, Mitchel L. |
|
Jan 1, 2005 |
774 |
| Enoxaparin matches heparin's efficacy in ACS. |
Zoler Mitchel L. |
|
Jun 1, 2004 |
1024 |
| Oral heparin takes a step forward, despite problems. (Liquid Form Limited by Bad Taste). |
Zoler, Mitchel L. |
|
Mar 1, 2003 |
469 |
| Postphlebitic Ulcer risk higher with Warfarin. (Compared to LMWH). |
DeMott, Kathryn |
|
Mar 1, 2002 |
253 |
| Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein a: use in first-trimester screening for down syndrome. |
Qin, Qiu-Ping; Christiansen, Michael; Pettersson, Kim |
|
Mar 1, 2002 |
7598 |
| Drug Update: Outpatient Treatment of Deep Vein Thrombosis. |
Zoler, Mitchel L.; Imperio, Winnie Anne |
|
Dec 1, 2001 |
853 |
| Different heparin lots: does it matter? |
Smythe, Maureen A.; Koerber, John M.; Westley, Susan J.; Balasubramaniam, Mamtha; Mattson, Joan C. |
|
Nov 1, 2001 |
2108 |
| Venous Thromboembolism. |
Fowler, Susan B. |
Brief Article |
Aug 1, 2001 |
163 |
| Quality improvement efforts in the intensive care unit: development of a new heparin protocol. |
Baird, Robert W. |
Clinical report |
Jul 1, 2001 |
2187 |
| Evaluation of the TAS analyzer and the Low-Range Heparin Management Test in patients undergoing extracorporeal membrane oxygenation. |
Ambrose, Theresa M.; Parvin, Curtis A.; Mendeloff, Eric; Luchtman-Jones, Lori |
Clinical report |
May 1, 2001 |
4613 |
| Heparin-induced release of protein-bound solutes during hemodialysis is an in vitro artifact. |
De Smet, Rita; van Kaer, Jacqueline; Liebich, Hartmut; Lesaffer, Gerrit; Verstraete, Alain; Dhondt, |
|
May 1, 2001 |
6978 |
| More on troponin assays and heparin. |
Buechler, Kenneth F.; Nakamura, Kevin K.; Gerhardt, Willie; Nordin, Gunnar; Isaksson, Anders; Haglun |
Letter to the editor |
Jan 1, 2001 |
2960 |
| Pathophysiology of Heparin-Induced Thrombocytopenia. |
Fabris, Fabrizio; Ahmad, Sarfraz; Cella, Giuseppe; Jeske, Walter P.; Walenga, Jeanine M.; Fareed, Ja |
|
Nov 1, 2000 |
8656 |
| Low molecular weight heparins: how they work ... what they do. |
Hillis, Laurie Berg |
|
Jun 1, 1998 |
2232 |
| Soft-water system cause of endotoxin in heparin. |
|
|
May 1, 1998 |
1031 |
| Plasma lipoprotein profiles change significantly during cardiac catheterization. |
Miida, Takashi; Otsuka, Hideaki; Tsuchiya, Atsushi; Okada, Masahiko |
|
Mar 1, 1998 |
3127 |
| Improved protamine-sensitive membrane electrode for monitoring heparin concentrations in whole blood via protamine titration. |
Ramamurthy, Narayanan; Baliga, Narayan; Wahr, Joyce A.; Schaller, Ulrich; Yang, Victor C.; Meyerhoff |
|
Mar 1, 1998 |
4745 |
| Zackfoot Investments Initiates Coverage of Emisphere Technologies with 'Strong Buy' |
|
|
Aug 29, 1997 |
237 |
| Heparin interference with sodium and albumin assays. |
Karon, Brad S.; Kempe, Kirsten C.; Scott, Mitchell G. |
Letter to the editor |
Apr 1, 1997 |
888 |
| Emisphere and Elan Finalize Joint Venture Agreement |
|
|
Sep 27, 1996 |
325 |
| STUDY SHOWS ENOXAPARIN MORE EFFECTIVE THAN WARFARIN IN PREVENTING BLOOD CLOTS AFTER KNEE SURGERY |
|
|
Apr 1, 1996 |
599 |
| LARGE MULTI-CENTER TRIAL TO DETERMINE BENEFITS OF LOW MOLECULAR WEIGHT HEPARIN IN UNSTABLE ANGINA |
|
|
Nov 13, 1995 |
633 |
| TEXAS BIOTECHNOLOGY INITIATES SECOND PIVOTAL PHASE III TRIAL FOR NOVASTAN |
|
|
Nov 7, 1995 |
489 |
| FRAGMIN, A NEW ONCE-DAILY LOW-MOLECULAR-WEIGHT HEPARIN, IS INTRODUCED FOR PREVENTION OF DEEP VEIN THROMBOSIS FOLLOWING ABDOMINAL SURGERY |
|
|
Nov 1, 1995 |
706 |
| RPR ANNOUNCES NEW PROGRAM WITH QUANTUM TO ADMINISTER LOVENOX(R) (ENOXAPARIN SODIUM) TO PATIENTS IN A HOMECARE SETTING |
|
|
Sep 25, 1995 |
500 |
| TEXAS BIOTECHNOLOGY INITIATES PHASE II/III CLINICAL STUDY OF NOVASTAN(R), NOVEL THROMBIN INHIBITOR |
|
|
May 3, 1995 |
460 |
| ELAN CORPORATION ANNOUNCES BREAKTHROUGH IN ORAL DELIVERY OF LARGE MOLECULES |
|
|
Oct 7, 1993 |
300 |
| Shooting down those postop clots. |
|
|
May 14, 1988 |
238 |
|
